Form 8-K - Current report:
SEC Accession No. 0001213900-24-108617
Filing Date
2024-12-13
Accepted
2024-12-13 08:20:08
Documents
16
Period of Report
2024-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0224537-8k_china.htm   iXBRL 8-K 33037
2 FORM OF THE SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 12, 2024, BY AND BETWE ea022453701ex1-1_china.htm EX-1.1 97070
3 OPINION OF FLANGAS LAW GROUP ea022453701ex5-1_china.htm EX-5.1 21099
4 PRESS RELEASE ANNOUNCING THE ENTRY OF THE AT-THE-MARKET EQUITY FINANCING ea022453701ex99-1_china.htm EX-99.1 8330
  Complete submission text file 0001213900-24-108617.txt   366323

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20241212.xsd EX-101.SCH 3048
6 XBRL LABEL FILE cphi-20241212_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE cphi-20241212_pre.xml EX-101.PRE 22381
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0224537-8k_china_htm.xml XML 3779
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 241546875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)